Cost-effectiveness of Prosorba column therapy for rheumatoid arthritis: a framework for analysis.

Cost-effectiveness of Prosorba column therapy for rheumatoid arthritis: a framework for analysis.

Apheresis with the Prosorba column is safe and effective for treating refractory rheumatoid arthritis. It also is resource intensive. Economic evaluation of Prosorba column therapy could help promote efficient use of this technology. This article describes a framework and the data requirements for a...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Griffiths, R, Slurzberg, J
Format:	Journal article
Sprog:	English
Udgivet:	2001

Lignende værker

Medical resource use and costs among rheumatoid arthritis patients receiving disease-modifying antirheumatic drug therapy.
af: Griffiths, R, et al.
Udgivet: (2000)

Pathogenesis and therapy of rheumatoid arthritis.
af: Williams, R
Udgivet: (2006)

Cytokine therapy in rheumatoid arthritis.
af: Maini, R, et al.
Udgivet: (1996)

Indirect costs of the Rheumatoid arthritis in Poland
af: Emilia Howoruszko, et al.
Udgivet: (2019-05-01)

Indirect costs of the Rheumatoid arthritis in Poland
af: Emilia Howoruszko, et al.
Udgivet: (2019-05-01)

Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis
af: Cynthia Said, et al.
Udgivet: (2013-01-01)

Effectiveness and costs of multidisciplinary care in patients with rheumatoid arthritis
af: S.M.M. Verstappen
Udgivet: (2003-08-01)

Gene therapy for rheumatoid arthritis?
af: Feldmann, M
Udgivet: (2001)

Antibody therapy for rheumatoid arthritis.
af: Taylor, P
Udgivet: (2003)

Adjunctive Therapies in Rheumatoid Arthritis
af: Tonatiuh González Heredia, et al.
Udgivet: (2024-11-01)

Infliximab in the therapy of rheumatoid arthritis
af: G. V. Lukina, et al.
Udgivet: (2016-05-01)

BIOBEHAVIORAL THERAPY OF RHEUMATOID ARTHRITIS
af: N. A. Shabanova, et al.
Udgivet: (2013-04-01)

Biologic therapy of rheumatoid arthritis
af: Damjanov Nemanja, et al.
Udgivet: (2009-01-01)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
af: Feldmann, M, et al.
Udgivet: (2011)

Anti-cytokine therapy for rheumatoid arthritis.
af: Maini, R, et al.
Udgivet: (2000)

The cost-effectiveness of biologics for the treatment of rheumatoid arthritis: a systematic review.
af: Jaana T Joensuu, et al.
Udgivet: (2015-01-01)

Female patients with rheumatoid arthritis – hospitalisation costs
af: Luana Andreea Macovei, et al.
Udgivet: (2019-12-01)

Clinical and cost effectiveness of arthritis gloves in rheumatoid arthritis (A-GLOVES): randomised controlled trial with economic analysis
af: Alison Hammond, et al.
Udgivet: (2021-01-01)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
af: Isaacs, J, et al.
Udgivet: (1992)

Cost-minimization analysis of subcutaneous abatacept in the treatment of rheumatoid arthritis in Spain
af: R. Ariza, et al.
Udgivet: (2014-07-01)

Humanised monoclonal antibody therapy for rheumatoid arthritis.
af: Isaacs, J, et al.
Udgivet: (1992)

Leflunomide and rheumatoid arthritis: a systematic review of effectiveness, safety and cost implications
af: Hewitson, P, et al.
Udgivet: (2001)

The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis
af: Allan Wailoo, et al.
Udgivet: (2017-11-01)

Exploitation of the IDO Pathway in the Therapy of Rheumatoid Arthritis.
af: Williams, R
Udgivet: (2013)

Fibrinolytic activity in rheumatoid arthritis and the effects of prednisolone therapy
af: Gough, S, et al.
Udgivet: (1993)

EFFECT OF INTRAMUSCULAR GOLD THERAPY ON THE COURSE OF RHEUMATOID ARTHRITIS
af: Soroush, et al.
Udgivet: (1996-06-01)

EFFECT OF INTRAMUSCULAR GOLD THERAPY ON THE COURSE OF RHEUMATOID ARTHRITIS
af: Soroush, et al.
Udgivet: (1996-06-01)

Certolizumab pegol in therapy for rheumatoid arthritis
af: Galina Viktorovna Lukina, et al.
Udgivet: (2012-06-01)

Part II. Therapy for rheumatoid arthritis
af: Natalia Viktorovna Demidova
Udgivet: (2013-12-01)

EFFICIENCY OF PHOTOMAGNETIC THERAPY IN RHEUMATOID ARTHRITIS
af: Voichenko N. V., et al.
Udgivet: (2020-06-01)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
af: Maini, R, et al.
Udgivet: (1994)

Markov's model of decision making on basic therapy of rheumatoid arthritis: monotherapy and its cost
af: D V Goryachev, et al.
Udgivet: (2004-05-01)

Associations of Cost Sharing With Rheumatoid Arthritis Disease Burden
af: Sharon Dowell, et al.
Udgivet: (2023-08-01)

Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis
af: Martin J. Bergman, et al.
Udgivet: (2020-08-01)

Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
af: Findeisen KE, et al.
Udgivet: (2021-08-01)

Dual Biologic Therapy in Patients with Rheumatoid Arthritis and Psoriatic Arthritis
af: Victoria Furer, et al.
Udgivet: (2023-04-01)

Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain
af: Schlueter M, et al.
Udgivet: (2019-06-01)

Analysis of biologic therapy in rheumatoid arthritis in a southern Spanish hospital population
af: Martínez-Perez R, et al.
Udgivet: (2010-11-01)

A COST VARIATION ANALYSIS OF DRUGS PRE-SCRIBED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
af: Yash Panchal, et al.
Udgivet: (2023-03-01)

Rheumatoid arthritis.
af: Feldmann, M, et al.
Udgivet: (1996)